[New drugs in oncology]
1Medizinische Klinik 1 (Gastroenterologie, Hepatologie, Infektiologie), Universitätsklinikum Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Deutschland, nisar.malek@med.uni-tuebingen.de.
Der Internist
|March 13, 2014
Summary
Recent oncology drug development targets molecular changes in tumors, including cancer stem cells and c-MET signaling. Innovative treatments like immune checkpoint inhibitors and oncolytic viruses show promise for improving patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Recent innovations in oncology drug development focus on targeting specific molecular alterations in malignant tumors.
- Personalized medicine approaches are increasingly utilized, tailoring treatments to individual tumor characteristics.
Purpose of the Study:
- To review emerging therapeutic targets and novel drug candidates in oncology.
- To highlight advancements in overcoming drug resistance and improving patient outcomes.
Main Methods:
- Review of current research and clinical trial data on novel oncological treatments.
- Analysis of targeted therapies, including small molecule inhibitors and immunotherapies.
- Evaluation of emerging treatment modalities such as oncolytic viruses and epigenetic drugs.
Main Results:
- New targets identified, including cancer stem cells and c-MET signaling pathways.
- Immune checkpoint inhibitors (e.g., CTLA4 antibodies) demonstrate significant clinical trial success.
- Epigenetic drugs and oncolytic viruses show potential in overcoming drug resistance and treating specific tumor types.
Conclusions:
- The next few years will bring significant advancements in oncological treatments.
- New drugs and therapeutic options are expected to improve patient survival rates in cancer care.
Related Concept Videos
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
02:57Targeted Cancer Therapies
1.4K
1.4K
02:49Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
02:49Cancer Therapies
2.4K
2.4K
02:56Treatment Resistent Cancers
1.1K
1.1K
02:56Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K